Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Plastic Bronchitis
NCT03942926Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sirolimus in plastic bronchitis (PB), sponsored by Peking Union Medical College Hospital. Primary endpoints: Changes of pulmonary lymphatic perfusion distribution at 6 months and Changes of coughing score at 6 months. Status: unknown.
02
Drugs
sirolimus
03
Conditions
plastic bronchitis (PB)
Beyond the preview
Go deeper on NCT03942926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03942926.